Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Mass Balance of Trazpiroben (TAK-906) in Healthy Males
NCT04454918Phase 1Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of trazpiroben in gastroparesis, sponsored by Millennium Pharmaceuticals. Primary endpoints: Absolute Bioavailability Based on Ratio of Dose Normalized Area Under the Plasma Concentration-time Curve From Time 0 to Infinity, Cumulative Percentage of Total Radioactivity Excreted in Urine and 2 more. Started Jul 2020; status: completed.
02
Drugs
trazpiroben
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT04454918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454918.